Faculty Opinions recommendation of Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.

2021 ◽  
Author(s):  
Prem Subramanian
Keyword(s):  
Eye Drops ◽  
Pediatric Ophthalmology ◽  
Horner Syndrome

The comparative efficacy and tolerability of the latest fluoroquinolones in pediatric ophthalmology

2013 ◽  
Vol 4 (2) ◽  
pp. 32-36
Author(s):  
Tatiana Nikolaevna Vorontsova ◽  
Maria Vitalievna Mikhailova ◽  
Tatiana Vyacheslavovna Smoljaninova ◽  
Vladimir Vsevolodovich Brzheskiy
Keyword(s):  
Tear Film ◽  
Clinical Effectiveness ◽  
Eye Drops ◽  
Pediatric Ophthalmology ◽  
Comparative Efficacy ◽  
Bacterial Conjunctivitis ◽  
Film Stability ◽  
The Third ◽  
Results Of Treatment ◽  
Tear Film Stability

The authors analyze the results of treatment of 45 children with bacterial conjunctivitis (87 eyes). All patients were divided into 3 groups: children of the first group received instillations of 0.3 % ofloxacin (Uniflox, Unimed Pharma), the second — 0.5 % levofloxacin (Oftaquix, Santen or Signizef, Promed Exports), the third — 0.3 % ciprofloxacin (Ciprolet, Dr Reddy`s Laboratories; Cilloxan, Alcon; Cipromed, Promed Exports). The patients received one of the above-mentioned fluoroquinolones 1 drop to each eye 5 times a day during 7 days. All patients were examined: plating of conjunctival cavity content, biomicroscopy of cornea and conjunctiva, staining of cornea and conjunctiva with fluorescein, measurement of tear film stability. All patients filled the questionnaire to estimate the tolerability of drugs. Results: eye drops containing 0.3 % ofloxacin, 0.5 % levofloxacin and 0.3 % ciprofloxacin showed equally high clinical effectiveness. The tolerability of ofloxacin and lexofloxacin drops was higher than ciprofloxacin according to subjective and objective (toxic effect to cornea) criteria.

Sign in / Sign up

Export Citation Format

Share Document